"WuXi AppTec's Transfer of Intellectual Property to China Raises Supply-Chain Risks for US Drug Companies"
TL;DR
US intelligence officials informed Congress that WuXi AppTec transferred a US client's intellectual property to Chinese authorities without consent, raising concerns about the company and other unnamed Chinese firms engaging in activities contrary to US interests.
Topics:businesstechnology#chinese-authorities#intellectual-property#technology#us-china-relations#us-intelligence#wuxi-apptec
- US intelligence officials told Congress that WuXi transferred IP to Chinese authorities — report Endpoints News
- Exclusive: China's WuXi AppTec shared US client's data with Beijing, US intelligence officials told senators Reuters
- Intelligence officials warned lawmakers WuXi AppTec furnished China with client's intellectual property: Reuters FiercePharma
- U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies The Wall Street Journal
- Anti-China bills portend massive blow to biotech: BioCentury survey BioCentury
Want the full story? Read the original reporting
Read on Endpoints News